Get the Stockscreener App
6.35
4.87%
-0.325
After Hours:
6.30
-0.05
-0.79%
Clene Inc stock is traded at $6.35, with a volume of 61,051.
It is down -4.87% in the last 24 hours and up +11.01% over the past month.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.
See More
Previous Close:
$6.675
Open:
$6.7
24h Volume:
61,051
Relative Volume:
0.65
Market Cap:
$74.79M
Revenue:
$200.00K
Net Income/Loss:
$-26.17M
P/E Ratio:
-2.4446
EPS:
-2.5976
Net Cash Flow:
$-18.63M
1W Performance:
-0.78%
1M Performance:
+11.01%
6M Performance:
-28.57%
1Y Performance:
+106.84%
1-Day Range:
$6.225
$6.80
1-Week Range:
$5.915
$6.80
52-Week Range:
$2.2801
$13.50
Clene Inc Stock (CLNN) Company Profile
Name
Clene Inc
Sector
Industry
Phone
801-676-9695
Address
6550 SOUTH MILLROCK DRIVE, SUITE G50, SALT LAKE CITY
Compare CLNN vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CLNN
Clene Inc
|
6.35 | 78.62M | 200.00K | -26.17M | -18.63M | -2.5976 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Clene Inc Stock (CLNN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-04-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Jul-18-22 | Initiated | H.C. Wainwright | Buy |
| May-02-22 | Initiated | Canaccord Genuity | Buy |
| Sep-28-21 | Initiated | Oppenheimer | Outperform |
Clene Inc Stock (CLNN) Latest News
Top Nanotechnology Stocks To Keep An Eye OnApril 15th - MarketBeat
Top Nanotechnology Stocks To ConsiderApril 13th - MarketBeat
Nanotechnology Stocks To ResearchApril 12th - MarketBeat
Nanotechnology Stocks To Follow NowApril 11th - MarketBeat
Stock Report: Will Clene Inc outperform tech stocks2026 Opening Moves & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
Clene : 2025 Annual Report to Stockholders - marketscreener.com
Clene : 2025 Proxy Statement - marketscreener.com
Clene (NASDAQ: CLNN) sets 2026 votes on directors, pay and 1M-share stock plan boost - Stock Titan
Nanotechnology Stocks To ConsiderApril 10th - MarketBeat
ETF Watch: Is Clene Inc Equity Warrant in a consolidation phase2026 Technical Patterns & Fast Entry Momentum Trade Alerts - baoquankhu1.vn
CLNN.O PE Ratio & Valuation, Is CLNN.O Overvalued - Intellectia AI
Aug Big Picture: How do insiders feel about Clene Inc Equity WarrantVolume Spike & Weekly Momentum Stock Picks - baoquankhu1.vn
Nanotechnology Stocks Worth WatchingApril 7th - MarketBeat
Does Clene Inc Equity Warrant stock have upside surprise potential2026 Action & Accurate Buy Signal Alerts - baoquankhu1.vn
Insider Selling: Clene (NASDAQ:CLNN) Major Shareholder Sells 24,925 Shares of Stock - MarketBeat
Clene Inc. ten percent owner Ugwumba sells $119,889 in stock By Investing.com - Investing.com South Africa
Clene Inc. ten percent owner Ugwumba sells $119,889 in stock - Investing.com
Published on: 2026-04-07 04:42:49 - baoquankhu1.vn
Clene (CLNN) major holder sells 24,925 shares at $4.81 - Stock Titan
Top Nanotechnology Stocks To Follow NowApril 5th - MarketBeat
CLNN SEC FilingsClene 10-K, 10-Q, 8-K Forms - Stock Titan
Best Nanotechnology Stocks To Keep An Eye OnApril 4th - MarketBeat
Clene (NASDAQ:CLNN) Major Shareholder Sells $21,261.66 in Stock - MarketBeat
CLNNW SEC FilingsClene 10-K, 10-Q, 8-K Forms - Stock Titan
Clene Inc. ten percent owner sells $21k in stock By Investing.com - Investing.com Australia
Clene Inc. ten percent owner sells $21k in stock - investing.com
Clene (CLNN) 10% holder’s LLC sells 4,278 shares, keeps 426,816 - Stock Titan
Promising Nanotechnology Stocks To ResearchApril 1st - MarketBeat
Clene Inc. (CLNN) ten percent owner sells $494k in stock - Investing.com India
Symbiosis II sells multiple CLNN shares (NASDAQ: CLNN) in early 2026 - Stock Titan
Entity linked to Clene (CLNN) sells 100,997 common shares - Stock Titan
Sentiment Review: Is Clene Inc a play on infrastructure spending2026 Trading Recap & Technical Analysis for Trade Confirmation - baoquankhu1.vn
EPS Watch: What hedge funds are buying Clene Inc Equity WarrantMarket Volume Summary & Consistent Profit Focused Trading Strategies - baoquankhu1.vn
Market Outlook: Should I buy Clene Inc Equity Warrant stock now2026 Fed Impact & Short-Term Trading Alerts - baoquankhu1.vn
Clene Inc. ten percent owner sells $99k in shares By Investing.com - Investing.com India
Aug Catalysts: Is Clene Inc a top pick in the sectorTrade Risk Summary & Smart Allocation Stock Reports - baoquankhu1.vn
Clene Inc. ten percent owner sells $99k in shares - Investing.com
Clene (CLNN) holder SymBiosis II sells 17,909 common shares - Stock Titan
Top Nanotechnology Stocks To Add to Your WatchlistMarch 25th - MarketBeat
Risk Analysis: Can Clene Inc reach resistance levels soon2026 Winners & Losers & High Accuracy Investment Signals - baoquankhu1.vn
Aug Big Picture: Will Clene Inc benefit from AI trendsGlobal Markets & Growth Focused Entry Reports - baoquankhu1.vn
Symbiosis II LLC plans resale of CLNN (NASDAQ: CLNN) — 477,000 shares - Stock Titan
Clene Inc Stock (CLNN) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.69%
0.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):